-
Identifying environmental chemicals as agonists of the androgen receptor by using a quantitative high-throughput screening platform.
Toxicology 20170615
-
Penetration of prulifloxacin into sinus mucosa of patients undergoing paranasal sinus elective endoscopic surgery.
Journal of chemotherapy (Florence, Italy) 20120201
-
Semen quality in patients with Chlamydia trachomatis genital infection treated concurrently with prulifloxacin and a phytotherapeutic agent.
Journal of andrology 20120101
-
Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.
Chemotherapy 20120101
-
Development and validation of a liquid chromatography-tandem mass spectrometry method to determine ulifloxacin, the active metabolite of prulifloxacin in rat and rabbit plasma: application to toxicokinetic study.
Biomedical chromatography : BMC 20110801
-
Effects of levofloxacin, moxifloxacin and prulifloxacin on murine gut colonization by Candida albicans.
Medical mycology 20110501
-
Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections.
International journal of antimicrobial agents 20110401
-
(99m)Tc-prulifloxacin in artificially infected animals. Radiosynthesis and biological evaluation.
Nuklearmedizin. Nuclear medicine 20110101
-
[Susceptibility surveillance of clinical isolates to fluoroquinolone antimicrobial agents from 2003 to 2008: post-marketing study of prulifloxacin].
The Japanese journal of antibiotics 20100601
-
Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study.
Clinical drug investigation 20100101
-
In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.
BMC microbiology 20100101
-
Prulifloxacin ECG study.
Clinical drug investigation 20100101
-
Re: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
International journal of antimicrobial agents 20090901
-
Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
International journal of antimicrobial agents 20090601
-
Prulifloxacin as a trigger of myasthenia gravis.
Journal of the neurological sciences 20090515
-
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
Future microbiology 20090201
-
Penetration of orally administered prulifloxacin into human prostate tissue.
Clinical drug investigation 20090101
-
Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
Drug metabolism and pharmacokinetics 20090101
-
Effects of grepafloxacin on the function of human polymorphonuclear leukocytes and the phosphorylation of p38 mitogen-activated protein kinase.
Chemotherapy 20090101
-
Determination of ulifloxacin, the active metabolite of prulifloxacin, in human plasma by a 96-well format solid-phase extraction and capillary zone electrophoresis.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080901
-
Capillary electrophoresis-chemiluminescence determination of norfloxacin and prulifloxacin.
Analytica chimica acta 20080815
-
Simultaneous determination of Ciprofloxacin and the active metabolite of Prulifloxacin in aqueous human humor by high-performance liquid chromatography.
Journal of pharmaceutical and biomedical analysis 20080715
-
Determination of adenosine disodium triphosphate using prulifloxacin-terbium(III) as a fluorescence probe by spectrofluorimetry.
Analytica chimica acta 20080310
-
Highly sensitive spectrofluorimetric determination of trace amounts of prulifloxacin using the aluminium(III)-prulifloxacin system.
Luminescence : the journal of biological and chemical luminescence 20080101
-
Transporter-mediated hepatic uptake of ulifloxacin, an active metabolite of a prodrug-type new quinolone antibiotic prulifloxacin, in rats.
Drug metabolism and pharmacokinetics 20071001
-
Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20071001
-
Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study.
European journal of medicinal chemistry 20070701
-
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
International journal of antimicrobial agents 20070601
-
Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
Journal of chemotherapy (Florence, Italy) 20070601
-
Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis.
International journal of chronic obstructive pulmonary disease 20070301
-
Penetration of prulifloxacin into gynaecological tissues after single and repeated oral administrations.
Drugs in R&D 20070101
-
Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060307
-
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20060301
-
Prulifloxacin: a new antibacterial fluoroquinolone.
Expert review of anti-infective therapy 20060201
-
Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.
Pulmonary pharmacology & therapeutics 20060101
-
Pharmacologic characteristics of prulifloxacin.
Pulmonary pharmacology & therapeutics 20060101
-
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.
International journal of antimicrobial agents 20051101
-
Interpretive criteria for disk diffusion susceptibility testing of ulifloxacin, the active metabolite of prulifloxacin.
Journal of chemotherapy (Florence, Italy) 20050401
-
Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections.
Urologia internationalis 20050101
-
Penetration of orally administered prulifloxacin into human lung tissue.
Clinical pharmacokinetics 20050101
-
Prulifloxacin.
Drugs 20040101
-
Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk.
European journal of pharmacology 20030905
-
Involvement of multiple transport systems in the disposition of an active metabolite of a prodrug-type new quinolone antibiotic, prulifloxacin.
Drug metabolism and pharmacokinetics 20030101
-
[In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].
The Japanese journal of antibiotics 20021201
-
[In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
The Japanese journal of antibiotics 20021201
-
[Inhibitory activity of NM394, the active form of prodrug prulifloxacin against type II topoisomerase from Pseudomonas aeruginosa].
The Japanese journal of antibiotics 20021201
-
Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
Respiration; international review of thoracic diseases 20020101
-
Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Arzneimittel-Forschung 19961201
